Sandbox: m: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px"
{| style="border: 0px; font-size: 90%; margin: 3px; width: 500px"
|valign=top|
|valign=top|
|+  '''Cardiac Myxoma'''
|+  '''Cardiac Myxoma'''
Line 9: Line 9:


| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''General aspects'''|| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''General aspects'''|| style="padding: 5px 5px; background: #F5F5F5;" |
:* Older age at the time of diagnosis is associated with a worse prognosis.
:*Isolated cells with irregular cellular borders, mild or no atypia, no mitosis


|-
|-


| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Genetics'''|| style="padding: 5px 5px; background: #F5F5F5;"|
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Genetics'''|| style="padding: 5px 5px; background: #F5F5F5;"|
:* Males are associated with a worse prognosis when compared to females.
:*[[PRKAR1A]] gene plays an important role in cardiac development and myxomagenesis
|-
|-




| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Gross Pathology'''|| style="padding: 5px 5px; background: #F5F5F5;"|
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Gross Pathology'''|| style="padding: 5px 5px; background: #F5F5F5;"|
:* Patient's poor [[performance status]] is associated with a worse prognosis.
:*Smooth, lobulated mass can be friable or gelatinous
|-
|-


| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Micropathology'''|| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Micropathology'''|| style="padding: 5px 5px; background: #F5F5F5;" |
:*Binet stages B and C or Rai stages 2-4 are associated with a worse prognosis.
:*Inflammatory infiltrate with hemosiderin, calcifications and extramedullary hemopoyesis


|-
|-


| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Inmunohistochemistry'''|| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Inmunohistochemistry'''|| style="padding: 5px 5px; background: #F5F5F5;" |
:*A rapid [[lymphocyte]] doubling time is associated with a worse prognosis.
:*Vimentin, endothelial and neural markers




|}
|}

Latest revision as of 15:13, 24 November 2015

Cardiac Myxoma
Features Description
General aspects
  • Isolated cells with irregular cellular borders, mild or no atypia, no mitosis
Genetics
  • PRKAR1A gene plays an important role in cardiac development and myxomagenesis
Gross Pathology
  • Smooth, lobulated mass can be friable or gelatinous
Micropathology
  • Inflammatory infiltrate with hemosiderin, calcifications and extramedullary hemopoyesis
Inmunohistochemistry
  • Vimentin, endothelial and neural markers


Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox:_m&oldid=1189953"